Health Condition 1: H00-H59- Diseases of the eye and adnexa
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Amanta Healthcare Limited
Eupraxia Centre For Clinical Excellence LLP
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Patients above >=18 years of age. 2. Patients who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained. 3. Patients having moderate to severe symptoms suggestive of conditions such as irritation, discomfort, burning, stinging and itching due to loose foreign material in the eyes wherein the study product would be prescribed by Investigator as part of standard of care. 4. Patients who have been prescribed study product by Investigator as part of standard of care (SOC) practice and consent has been provided by patient post prescription of study product on the same day.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. Patients having any ocular diseases (corneal abrasion, ocular infection, foreign body trapping or ocular trauma), present or past, other than dry eye 2. History of ocular surgery 3. Patients using contact lens or topic treatments other than tear substitutes 4. History of intolerance or hypersensitivity to any component of the study medications 5. Patients participating in any other clinical trial during study 6. Pregnant/lactating women during study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study is to evaluate the efficacy and safety of 0.9% sodium chloride eye wash in real world patients.Timepoint: Baseline and day 10 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactRajdeep Patel
Lal Hospital
Outcome results
None listed